Aquestive Therapeutics (AQST) EBIT (2017 - 2026)
Aquestive Therapeutics (AQST) posted quarterly EBIT of -$4.2 million for Q1 2026, up 78.29% year-over-year from -$2.4 million in Q1 2025, and up 85.42% quarter-over-quarter from -$28.8 million in Q4 2025.
Aquestive Therapeutics (AQST) EBIT (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' EBIT history runs 10 years deep, the most recent figure standing at -$4.2 million for Q1 2026.
- In Q1 2026, EBIT rose 78.29% year-over-year to -$4.2 million; the TTM figure through Mar 2026 stood at -$55.9 million (down 35.72% YoY), while the FY2025 annual figure was -$71.1 million, down 130.9% from the prior year.
- EBIT for Q1 2026 stood at -$4.2 million, up from -$28.8 million in the prior quarter.
- The five-year high for EBIT was $55000.0 in Q2 2024, with the low at -$28.8 million in Q4 2025.
- The 5-year median for EBIT is -$9.0 million (2024), against an average of -$9.6 million.
- The sharpest annual moves came in 2024 and 2025: EBIT surged 101.31% in 2024, then sank 20769.09% in 2025.
- Aquestive Therapeutics' EBIT stood at -$10.7 million in 2022, then surged by 63.49% to -$3.9 million in 2023, then plunged by 247.2% to -$13.6 million in 2024, then sank by 112.38% to -$28.8 million in 2025, then jumped by 85.42% to -$4.2 million in 2026.
- Business Quant data shows AQST's EBIT at -$4.2 million in Q1 2026, -$28.8 million in Q4 2025, and -$11.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Aquestive Therapeutics | 558.10 Mn | 558.10 Mn | 9.80 Mn | -8.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.22 Mn |
| Mar 31, 2026 | -4.20 Mn |
| Dec 31, 2025 | -28.84 Mn |
| Sep 30, 2025 | -11.48 Mn |
| Jun 30, 2025 | -11.37 Mn |
| Mar 31, 2025 | -19.37 Mn |
| Dec 31, 2024 | -13.58 Mn |
| Sep 30, 2024 | -8.29 Mn |
| Jun 30, 2024 | 55,000.00 |
| Mar 31, 2024 | -8.96 Mn |
| Dec 31, 2023 | -3.91 Mn |
| Sep 30, 2023 | -2.38 Mn |
| Jun 30, 2023 | -4.21 Mn |
| Mar 31, 2023 | -4.61 Mn |
| Dec 31, 2022 | -10.71 Mn |
| Sep 30, 2022 | -8.85 Mn |
| Jun 30, 2022 | -12.76 Mn |
| Mar 31, 2022 | -9.74 Mn |
| Dec 31, 2021 | -11.67 Mn |
| Sep 30, 2021 | -7.97 Mn |